Navigation Links
CHPA Applauds New Mexico Adoption Of House Bill 146
Date:3/16/2013

WASHINGTON, March 16, 2013 /PRNewswire-USNewswire/ -- The Consumer Healthcare Products Association (CHPA) today applauded the New Mexico legislature for passing House Bill 146, an anti-methamphetamine bill authored by Representative Antonio "Moe" Maestas (D-16).  Once Governor Susana Martinez (R-N.M.) signs the bill into law, New Mexico will become the 27th state to adopt electronic pseudoephedrine (PSE) sales blocking technology.

Real-time, stop-sale technology is a proven and powerful tool that allows retailers and pharmacists to block unlawful attempted purchases of cold and allergy medicines containing PSE that exceed daily or monthly limits established by the 2005 Combat Methamphetamine Epidemic Act. While law-abiding consumers make the vast majority of PSE purchases, some hardened criminals illegally obtain these products in order to manufacture meth. Illegal sales blocking technology empowers retailers and law enforcement officials with the ability to track and block illegal sales of products containing PSE before they happen. Before this technology was in place, retailers had to manually record PSE purchases in a hand-written logbook—a cumbersome and ineffective system for preventing unlawful sales. Real-time, stop-sale technology is also a useful tool for police officers and narcotics agents. Law enforcement officials have instant access to PSE purchasing activity which can help determine if a suspect is purchasing PSE in order to manufacture meth.. The system is provided at no charge to the state.

"Shortly after Governor Martinez signs this important legislation into law, more than half the nation will be covered by pseudoephedrine tracking technology," said Scott Melville , president and chief executive officer of the Consumer Healthcare Products Association. "In addition to New Mexico, twenty-six states have chosen to adopt real-time, stop-sale technology because in addition to providing an exceptional resource to law enforcement and retailers, the technology ensures that law-abiding consumers continue to have access to the cold and allergy medicines they know and trust. More than 18 million American families rely on safe and effective medicines containing pseudoephedrine for relief from symptoms. We commend Representative Maestas for advancing legislation that targets criminals, not responsible New Mexico taxpayers."

CHPA is the 132-year-old-trade association representing U.S. manufacturers and distributors of over-the-counter medicines and dietary supplements.

chpa-info.org


'/>"/>
SOURCE Consumer Healthcare Products Association
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Watson Applauds GPhA Study Demonstrating $1 Trillion in Prescription Drug Savings from Generic Medicines
2. Mylan Applauds Study Highlighting $1 Trillion in Savings for U.S. Health Care System Due to Generic Drugs Over Past Decade
3. CRN Applauds Introduction Of Designer Anabolic Steroid Control Act
4. ADVENTRX Applauds Inclusion of Rare Diseases Provisions in the FDA Safety and Innovation Act
5. Mylan Applauds Signing of Landmark "Food and Drug Administration Safety and Innovation Act"
6. American Academy of Pain Medicine Applauds FDA Action to Enhance Patient Safety on Prescribing Opioids; Offers AAPM Safe Opioid Prescribing Course as Educational Model
7. Novation Applauds FDAs Unique Device Identification Rule
8. Obesity Care Continuum (OCC) Applauds FDA for Approval of New Obesity Drug
9. Omega Laboratories Applauds the Adoption of Enzyme Immunoassay (EIA) by Major Hair Testing Laboratories
10. CHPA Applauds Arizonas Adoption Of HB 2263
11. Lilly Applauds Law Enforcement Officials for their Successful Investigation and Recovery of Pharmaceuticals Stolen from Connecticut Distribution Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... CAESAREA, Israel , August 17, 2017 /PRNewswire/ ... digital health Company with mobile health and big ... securities purchase agreements with domestic and non-U.S. investors ... common stock and shares of the Company,s newly ... private placement offerings. The Company expects to conduct ...
(Date:8/15/2017)... , Aug. 15, 2017  Axium Pharmaceuticals Inc., the creator of the ... be in the beginning stages of an IPO. ... medications with the average cost of a prescription epilepsy drug being $450.00-$1200.00 ... AXIUM PHARMACEUTICALS, ... Another staggering figure is the fact that Americans ...
(Date:8/11/2017)... DarioHealth Corp. (NASDAQ: DRIO), a leading global ... solutions, today announced that it will release its second ... a conference call at 9:00am ET. The Company will ... and its strategy and outlook for the remainder of ... Raphael , Chief Executive Officer, and Zvi Ben-David ...
Breaking Medicine Technology:
(Date:8/18/2017)... ... August 18, 2017 , ... With over 16,000 active ... hormone replacement therapy and integrative medicine, has become a frontrunner for people seeking ... as menopause, andropause, thyroid disorder and adrenal insufficiencies. , Founded in 2003 ...
(Date:8/18/2017)... CA & CARMEL, IN (PRWEB) , ... August 18, 2017 , ... ... on its 36th annual list, the most prestigious ranking of the nation's fastest-growing private ... been included in the exclusive Inc. 5000 ranking . This year’s ranking reflects ...
(Date:8/18/2017)... , ... August 18, 2017 , ... “Dangerous Inheritance”: a ... author, Diane Winters. Diane is from Southwest Nebraska where she was raised on ... and family. The story is fictional, but the friendships and mantra of ‘neighbors ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Depressed: Super Heroes of ... readers to reflect upon the stories and the relevance these tales may have on ... author, Jessica Linhart, a former special education teacher, Jessica spends much of her time ...
(Date:8/18/2017)... ... , ... “Prompted By Love”: a love story thrown into doubt by untimely ... Author Mary P. Nettles has devoted her life to ministry since the age of ... to write was, however, not fulfilled until 2014 when "The Color of Roses" was ...
Breaking Medicine News(10 mins):